Study Evaluating the Safety and Efficacy of Brimonidine Tartrate Ophthalmic Solution in Adult and Geriatric Subjects

A Single-Center, Double-Masked, Randomized, Vehicle-Controlled, Parallel-Group Study Evaluating the Safety and Efficacy of Brimonidine Tartrate Ophthalmic Solution in Adult and Geriatric Subjects

The purpose of this study is to evaluate the safety and efficacy of brimonidine tartrate 0.025% ophthalmic solution used four times daily in a population of adult and geriatric subjects

Inclusion Criteria:

• Be at least 40 years of age
• Must have normal ocular health
• Must have history of redness relief drop use or desire to use

Exclusion Criteria:

• Must not have any ocular/systemic health problems
• Must agree to avoid disallowed medications